Budhiraja Pooja, Butterfield Richard, Gea-Banacloche Juan, Swaminathan Sundararaman, Smith Maxwell L, Khamash Hassan A, Me Hay Me, Kodali Lavanya, Mour Girish K, Nair Sumi, Misra Suman, Heilman Raymond L
Division of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Department of Statistics, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Clin Transplant. 2023 Dec;37(12):e15125. doi: 10.1111/ctr.15125. Epub 2023 Sep 13.
Urinary Tract Infections are the most common post-transplant infection and can have varied presentations. This study aimed to describe the outcomes of kidney transplant recipients with asymptomatic histologic pyelonephritis on allograft biopsy. Histologic Pyelonephritis was defined as neutrophil cast or neutrophilic tubulitis, interstitial infiltrates with predominant neutrophils, and no evidence of rejection or glomerulonephritis on biopsy.
The study included 123 kidney transplant recipients, of whom 95 underwent protocol biopsies, and 28 had biopsies for elevated creatinine within the first 2 years of a kidney transplant.
The mean age of the cohort was 55.3 years, with 52% females and 78% deceased donor transplants. The risk factors for asymptomatic histologic pyelonephritis were recipient female sex (OR 1.89, 1.3-2.7, diabetes mellitus (OR 2.479, 1.687-3.645), and deceased donation (OR 1.69, 1.098-2.63). The incidence of asymptomatic pyelonephritis on protocol biopsy was 1.7%, with 52% having positive urine cultures and Escherichia coli being the most common bacteria. Subjects with asymptomatic pyelonephritis had inferior graft survival compared to the matched cohort HR 1.88 (1.06-3.35), p = .0281. In addition, of these 123 subjects, 68 (55%) subsequently developed pyelonephritis, and 34 subjects had pyelonephritis within 6 months after this episode. Subjects with recurrent infections exhibited lower survival HR 2.86 (1.36-6.02) and a trend toward higher rejection risk.
Asymptomatic histologic pyelonephritis can occur in kidney transplant recipients and is associated with inferior graft survival.
尿路感染是移植后最常见的感染,临床表现多样。本研究旨在描述肾移植受者在移植肾活检时无症状性组织学肾盂肾炎的结局。组织学肾盂肾炎定义为中性粒细胞管型或中性粒细胞肾小管炎、以中性粒细胞为主的间质浸润,且活检无排斥反应或肾小球肾炎证据。
该研究纳入123例肾移植受者,其中95例行方案活检,28例在肾移植后2年内因肌酐升高而行活检。
该队列的平均年龄为55.3岁,女性占52%,78%为死亡供者肾移植。无症状性组织学肾盂肾炎的危险因素为受者女性(比值比1.89,1.3 - 2.7)、糖尿病(比值比2.479,1.687 - 3.645)和死亡供者肾移植(比值比1.69,1.098 - 2.63)。方案活检时无症状性肾盂肾炎的发生率为1.7%,52%尿培养阳性,大肠埃希菌是最常见的细菌。与匹配队列相比,无症状性肾盂肾炎患者的移植肾存活率较低,风险比为1.88(1.06 - 3.35),p = 0.0281。此外,在这123例受试者中,68例(55%)随后发生肾盂肾炎,34例在此次发作后6个月内发生肾盂肾炎。反复感染的受试者存活率较低,风险比为2.86(1.36 - 6.02),且有排斥风险升高的趋势。
无症状性组织学肾盂肾炎可发生于肾移植受者,且与移植肾存活率较低有关。